An Open Label Lesion Controlled Study of Electroporation Therapy (EPT) for the Treatment of Cutaneous Metastatic Melanoma Using the Genetronics, Inc. Medpulser System and Bleomycin.
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2011
At a glance
- Drugs Bleomycin (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 30 Sep 2005 New trial record.